News | October 06, 2008

ATS Medical Launches CryoMaze Surgical Ablation Clamp

October 7, 2008 - ATS Medical Inc. last week launched U.S. sales of the ATS CryoMaze Surgical Ablation Clamp.

The launch of this product marks the first ablation product development effort by ATS since the product line was acquired from CryoCath Technologies. The ATS CryoMaze Clamp is similar in clinical use to other ablation clamps on the market; however, it uses argon-based cryoablation to create lesions rather than heat-based RF energy. The benefit of this ablation clamp over competitive devices is a unique ablation window that allows the surgeon to visually confirm complete freezing of the targeted tissue, the company said. Early prototype testing and evaluation was performed with the assistance of Evelio Rodriguez, M.D., of East Carolina University, who has also used the clamp in clinical practice.

“Some other ablation clamps must be applied multiple times and then tested to see if they work,” said Dr. Rodriguez. “But with the ATS CryoMaze Clamp, you apply it once and, because you can see the frost coming through, you know that it worked with a single application.”

For more information: www.atsmedical.com


Related Content

News

Oct. 24, 2024 — Medtronic plc has announced United States Food and Drug Administration (FDA) approval of the Affera ...

Home October 30, 2024
Home
News

Oct. 18, 2024 — Boston Scientific Corp. recently announced it has received U.S. Food and Drug Administration (FDA) ...

Home October 21, 2024
Home
News

May 15, 2024 —CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac ...

Home May 15, 2024
Home
News

May 13, 2024 — Innovative Health, Inc. announced that recent growth in single-use device reprocessing has delivered ...

Home May 13, 2024
Home
News

October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6 ...

Home October 10, 2023
Home
News

August 9, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) ...

Home August 09, 2023
Home
News

January 31, 2023 —Imricor, a global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation ...

Home January 31, 2023
Home
News

December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias ...

Home December 21, 2022
Home
News

October 24, 2022 — Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac ...

Home October 24, 2022
Home
News

May 13, 2022 — Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are ...

Home May 13, 2022
Home
Subscribe Now